Esperion Therapeutics Share Holder Equity 2012-2025 | ESPR

Esperion Therapeutics share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Esperion Therapeutics Annual Share Holder Equity (Millions of US $)
2024	$-389
2023	$-455
2022	$-324
2021	$-197
2020	$-96
2019	$20
2018	$79
2017	$245
2016	$229
2015	$287
2014	$134
2013	$74
2012	$-17
2011	$-6

Esperion Therapeutics Quarterly Share Holder Equity (Millions of US $)
2025-09-30	$-451
2025-06-30	$-434
2025-03-31	$-426
2024-12-31	$-389
2024-09-30	$-370
2024-06-30	$-344
2024-03-31	$-294
2023-12-31	$-455
2023-09-30	$-410
2023-06-30	$-372
2023-03-31	$-330
2022-12-31	$-324
2022-09-30	$-294
2022-06-30	$-292
2022-03-31	$-249
2021-12-31	$-197
2021-09-30	$-363
2021-06-30	$-304
2021-03-31	$-269
2020-12-31	$-96
2020-09-30	$9
2020-06-30	$85
2020-03-31	$-50
2019-12-31	$20
2019-09-30	$69
2019-06-30	$129
2019-03-31	$175
2018-12-31	$79
2018-09-30	$132
2018-06-30	$176
2018-03-31	$214
2017-12-31	$245
2017-09-30	$278
2017-06-30	$154
2017-03-31	$192
2016-12-31	$229
2016-09-30	$254
2016-06-30	$268
2016-03-31	$278
2015-12-31	$287
2015-09-30	$296
2015-06-30	$305
2015-03-31	$314
2014-12-31	$134
2014-09-30	$50
2014-06-30	$59
2014-03-31	$67
2013-12-31	$74
2013-09-30	$83
2013-06-30	$13
2013-03-31	$0
2012-12-31
2012-09-30	$0
2012-06-30	$0
2011-12-31	$-6

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.849B	$0.332B
Esperion Therapeutics, Inc. is a pharmaceutical company focused on the development of oral lipid-management treatments for cardiovascular diseases caused by elevated levels of LDL-C (bad cholesterol).

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$89.220B	33.89
Zoetis (ZTS)	United States	$55.228B	19.77
Takeda Pharmaceutical (TAK)	Japan	$51.739B	10.56
Daiichi Sankyo, - (DSNKY)	Japan	$43.684B	21.75
BeOne Medicines - (ONC)	Switzerland	$36.626B	194.18
Sandoz Group AG (SDZNY)	Switzerland	$33.097B	0.00
United Therapeutics (UTHR)	United States	$20.770B	18.28
Merck (MKKGY)	Germany	$19.845B	12.23
Shionogi (SGIOY)	Japan	$15.823B	14.53
Neurocrine Biosciences (NBIX)	United States	$13.227B	31.74
Ionis Pharmaceuticals (IONS)	United States	$13.227B	0.00
Summit Therapeutics (SMMT)	United States	$13.140B	0.00
IPSEN (IPSEY)	France	$12.596B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.595B	0.00
Orion OYJ (ORINY)	Finland	$11.045B	31.56
Eisai (ESAIY)		$8.889B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.576B	20.00
Grifols, S.A (GRFS)	Spain	$6.284B	0.00
Stevanato Group S.p.A (STVN)	Italy	$6.278B	35.14
Crinetics Pharmaceuticals (CRNX)	United States	$5.252B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
Indivior (INDV)	United States	$4.321B	17.63
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.080B	19.37
Corcept Therapeutics (CORT)	United States	$3.930B	42.46
NewAmsterdam Pharma (NAMS)	Netherlands	$3.707B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$2.960B	0.00
Hypermarcas (HYPMY)	Brazil	$2.882B	19.78
Catalyst Pharmaceuticals (CPRX)	United States	$2.854B	9.11
Dyne Therapeutics (DYN)	United States	$2.494B	0.00
Ocular Therapeutix (OCUL)	United States	$2.277B	0.00
Soleno Therapeutics (SLNO)	United States	$2.231B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.100B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.015B	23.88
Guardian Pharmacy Services (GRDN)	United States	$1.995B	38.43
Ardelyx (ARDX)	United States	$1.788B	0.00
Harrow (HROW)	United States	$1.772B	108.73
Collegium Pharmaceutical (COLL)	United States	$1.522B	7.54
BioCryst Pharmaceuticals (BCRX)	United States	$1.494B	88.62
Oruka Therapeutics (ORKA)	United States	$1.486B	0.00
Enliven Therapeutics (ELVN)	United States	$1.485B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.361B	0.00
Relay Therapeutics (RLAY)	United States	$1.352B	0.00
Evotec AG (EVO)	Germany	$1.335B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.306B	0.00
Savara (SVRA)	United States	$1.174B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.125B	0.00
Cronos Group (CRON)	Canada	$1.025B	0.00
Xencor (XNCR)	United States	$1.012B	0.00
Theravance Biopharma (TBPH)	United States	$0.996B	41.81
KalVista Pharmaceuticals (KALV)	United States	$0.828B	0.00
Nektar Therapeutics (NKTR)	United States	$0.789B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.727B	17.19
Rigel Pharmaceuticals (RIGL)	United States	$0.725B	6.48
ProKidney (PROK)	United States	$0.701B	0.00
Bioventus (BVS)	United States	$0.641B	13.14
Lexeo Therapeutics (LXEO)	United States	$0.593B	0.00
Organogenesis (ORGO)	United States	$0.537B	0.00
Lyell Immunopharma (LYEL)	United States	$0.505B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.497B	0.00
Siga Technologies (SIGA)	United States	$0.472B	6.46
Zevra Therapeutics (ZVRA)	United States	$0.472B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.429B	0.00
Aquestive Therapeutics (AQST)	United States	$0.428B	0.00
Altimmune (ALT)	United States	$0.423B	0.00
Nature's Sunshine Products (NATR)	United States	$0.390B	23.25
USANA Health Sciences (USNA)	United States	$0.377B	10.51
Akebia Therapeutics (AKBA)	United States	$0.372B	0.00
Profound Medical (PROF)	Canada	$0.314B	0.00
Avalo Therapeutics (AVTX)	United States	$0.309B	0.00
Relmada Therapeutics (RLMD)	United States	$0.301B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.301B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.288B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.279B	0.00
OmniAb (OABI)	United States	$0.275B	0.00
Fractyl Health (GUTS)	United States	$0.274B	0.00
Heron Therapeutics (HRTX)	United States	$0.273B	0.00
Protara Therapeutics (TARA)	United States	$0.271B	0.00
Larimar Therapeutics (LRMR)	United States	$0.269B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.248B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.226B	0.00
Journey Medical (DERM)	United States	$0.210B	0.00
Galectin Therapeutics (GALT)	United States	$0.204B	0.00
VAXART, INC (VXRT)	United States	$0.192B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.192B	0.00
MediWound (MDWD)	Israel	$0.191B	0.00
Minerva Neurosciences (NERV)	United States	$0.187B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Century Therapeutics (IPSC)	United States	$0.178B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
AleAnna (ANNA)	United States	$0.155B	0.00
Surrozen (SRZN)	United States	$0.154B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.150B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.140B	0.00
Prelude Therapeutics (PRLD)	United States	$0.138B	0.00
Context Therapeutics (CNTX)	United States	$0.137B	0.00
Incannex Healthcare (IXHL)	Australia	$0.135B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.129B	0.00
Pyxis Oncology (PYXS)	United States	$0.128B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.128B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.126B	0.00
Avita Medical (RCEL)	United States	$0.104B	0.00
Cassava Sciences (SAVA)	United States	$0.102B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.096B	0.00
Vivani Medical (VANI)	United States	$0.093B	0.00
Champions Oncology (CSBR)	United States	$0.093B	39.53
Korro Bio (KRRO)	United States	$0.084B	0.00
Gain Therapeutics (GANX)	United States	$0.082B	0.00
PolyPid (PYPD)	Israel	$0.074B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.071B	59.00
Dominari Holdings (DOMH)	United States	$0.069B	0.00
Plus Therapeutics (PSTV)	United States	$0.068B	0.00
Arch Biopartners (ACHFF)	Canada	$0.067B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.066B	0.00
Metagenomi (MGX)	United States	$0.066B	0.00
Rafael Holdings (RFL)	United States	$0.064B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.062B	0.00
Assertio Holdings (ASRT)	United States	$0.060B	0.00
Lite Strategy (LITS)	United States	$0.053B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.051B	0.00
Nutriband (NTRB)	United States	$0.051B	0.00
ElectroCore (ECOR)	United States	$0.051B	0.00
Lipocine (LPCN)	United States	$0.050B	0.00
Talphera (TLPH)	United States	$0.048B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.046B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Wellgistics Health (WGRX)	United States	$0.039B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.037B	0.00
FibroGen (KYNB)	United States	$0.037B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.031B	0.00
Natural Alternatives (NAII)	United States	$0.029B	0.00
SCYNEXIS (SCYX)	United States	$0.028B	0.00
Klotho Neurosciences (KLTO)	United States	$0.025B	0.00
TherapeuticsMD (TXMD)	United States	$0.024B	0.00
Scienture Holdings (SCNX)	United States	$0.022B	0.00
Inotiv (NOTV)	United States	$0.021B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
Cosmos Health (COSM)	United States	$0.019B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Vivos Therapeutics (VVOS)	United States	$0.019B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Vyome Holdings (HIND)	United States	$0.018B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.017B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.017B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.014B	0.00
CASI Pharmaceuticals (CASI)	China	$0.013B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.012B	0.00
Mangoceuticals (MGRX)	United States	$0.011B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
Traws Pharma (TRAW)	United States	$0.010B	0.01
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.010B	0.00
BioVie (BIVI)	United States	$0.010B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.007B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Indaptus Therapeutics (INDP)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.006B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Salarius Pharmaceuticals (DCOY)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Clearmind Medicine (CMND)	Canada	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00